NY-EMPIRE-STATE-REALTY
22.3.2024 04:32:29 CET | Business Wire | Press release
The Empire State Building (ESB), in collaboration with Disney Consumer Products and Lucasfilm, today unveiled a Star Wars™-themed, villains-inspired takeover for fans in New York City that featured a dynamic light show, immersive experiences for visitors, character appearances, and participation from actor Hayden Christensen in a morning lighting ceremony. Fans who visit ESB this month will have the opportunity to immerse themselves into the Star Wars galaxy photo opportunities which feature a range of new Star Wars consumer products through April 29.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240321369670/en/
The Empire State Building Unveils Star Wars-Themed Takeover with a Dynamic Light Show, Interactive Fan Experiences, Celebrity Visit, and More (Photo: Business Wire)
"We are so pleased to unite Star Wars fans in New York City and throughout the world with this epic trip to a galaxy far, far away….,” said Jean-Yves Ghazi, president of the Empire State Building Observatory. “This one-of-a-kind takeover at the ‘World’s Most Famous Building’ allows fans to come face to face with pop culture’s most iconic villains in an authentic New York City way.”
Star Wars in Lights
This evening, a dynamic light show that featured fan-favorite scenes of Star Wars villains debuted on the building’s south side façade from 8 p.m. in continued intervals until 11 p.m. The montage was synched to the iconic “The Imperial March (Darth Vader’s Theme),” and was streamed simultaneously on iHeartRadio’s Z100 New York radio station and on the iHeartRadio app.
Star Wars actor Hayden Christensen visited the Empire State Building earlier this morning to tour the world-famous Observatory Experience and flip the ceremonial switch ahead of the dynamic light show.
Step into the Scenes
The Empire State Building’s iconic Fifth Avenue Lobby windows now feature special Star Wars-themed artistry that depicts scenes of Darth Vader, Darth Maul, and stormtroopers surrounded by a range of Star Wars merchandise, in collaboration with Disney Consumer Products and Lucasfilm. The window exhibit will remain on display until April 29.
At the base of the building, visitors can also join Hasbro and Amazon for a Star Wars fan experience on March 21-22 from 1-9 p.m. and on March 23 from 10-8 p.m. The experience highlights the villains of the Star Wars galaxy and features photo opportunities with costumed characters, which include Darth Vader and stormtroopers — as well as photo backdrops that recreate iconic scenes and locations inspired by the films like the opening hallway scene from Rogue One: A Star Wars Story, the Star Destroyer bridge, and Emperor Palpatine’s throne. Guests can also pose in the blister card packaging of a Star Wars Vintage Collection figure. Additionally, attendees will be able to check out the latest Hasbro Black Series helmets or wield their favorite character’s FX Elite or Kyber Core Lightsaber™ adult and kid collectibles.
To celebrate 25 years of the LEGO® Star Wars™ collaboration, the Empire State Building features a museum-quality display of life-sized Star Wars villains like six-foot tall brick-built recreations of Darth Vader and Darth Maul on the building’s 80th Floor. Fans also have the chance to pose with a 3D LEGO® Star Wars™ mural of Luke Skywalker and other fan-favorite characters from the film series. This exclusive LEGO® Star Wars™ exhibit will remain on display in the Observatory until April 29.
Once they reach the iconic 86th Floor Observatory, fans can pose for a photo with a life-size Darth Vader-themed POP! Figure from Funko with ESB’s unmatched New York City views as a backdrop until April 29. On March 21 and 22 from 10 a.m. to 1 p.m., Dairy Farmers of America will treat guests to samples of their new TruMoo Star Wars Blue Milk – inspired by the blue milk that made its first appearance in Star Wars: A New Hope.
“The Empire Strikes Back”
The Empire State Building Observatory will host a movie screening of Star Wars: The Empire Strikes Back on the 80th Floor on March 22. Guests who purchase tickets to the exclusive movie night will receive complimentary drinks and snacks to enjoy with the movie and access to the famed 86th and 102nd Floor Observatories. Tickets can be purchased here.
The Empire State Building Observatory recently underwent a $165 million reimagination that included the addition of a dedicated visitor entrance, an immersive museum with nine galleries, brand-new, bespoke Observatory Host uniforms, and a new 102nd Floor Observatory with unmatched views. The reimagined Observatory Experience has been voted the #1 attraction in the U.S. in Tripadvisor’s Travelers’ Choice Awards: Best of the Best for two consecutive years.
Text CONNECT to 274-16 to receive real-time information about the Empire State Building’s tower lights.
Hi-res imagery and video can be found here. More information about the Empire State Building can be found online.
Lucasfilm, the Lucasfilm logo, STAR WARS and related properties are trademarks and/or copyrights, in the United States and other countries, of Lucasfilm Ltd. and/or its affiliates. © & TM Lucasfilm Ltd.
About the Empire State Building
The Empire State Building, the “World's Most Famous Building," owned by Empire State Realty Trust, Inc. (ESRT: NYSE), soars 1,454 feet above Midtown Manhattan from base to antenna. The $165 million reimagination of the Empire State Building Observatory Experience creates an all-new experience with a dedicated guest entrance, an interactive museum with nine galleries, and a redesigned 102nd Floor Observatory with floor-to-ceiling windows. The journey to the world-famous 86th Floor Observatory, the only 360-degree, open-air observatory with views of New York and beyond, orients visitors for their entire New York City experience and covers everything from the building's iconic history to its current place in pop culture. The Empire State Building Observatory Experience welcomes millions of visitors each year and was declared "America's Favorite Building" by the American Institute of Architects, the world's most popular travel destination by Uber, the #1 attraction in the U.S. in Tripadvisor’s Travelers’ Choice Awards: Best of the Best for two consecutive years, and the #1 New York City attraction in Lonely Planet’s Ultimate Travel List.
Since 2011, the building has been fully powered by renewable wind electricity, and its many floors house a diverse array of office tenants such as LinkedIn and Shutterstock, as well as retail options like STATE Grill and Bar, Tacombi, and Starbucks. For more information and Observatory Experience tickets visit esbnyc.com or follow the building's Facebook, X (formerly Twitter), Instagram, Weibo, YouTube, or TikTok.
Source: Empire State Realty Trust
Category: Observatory
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240321369670/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom